SOPHiA DDM™ Enhanced Clinical Exome Solution

A comprehensive solution combining a capture-based enrichment kit and the SOPHiA DDM™ platform for advanced clinical exome analysis, featuring targeted enhancements to increase coverage in critical regions and detect complex variants in a single workflow.

Detailed Description

Operating Principle

A genomic application integrating a capture enrichment kit with the advanced analytical modules of the SOPHiA DDM™ platform. The solution expands the SOPHiA DDM™ Clinical Exome Solution v3 kit with targeted probes to boost coverage in critical genomic regions and dedicated algorithms that reliably detect hard-to-identify variants, all within a single test.

SOPHiA Clinical Exome Solution

Clinical Applications

Specially designed to advance the study of rare and hereditary diseases, and to consolidate indications such as carrier screening and hereditary cancer into a unified workflow.

Benefits

Increases laboratory efficiency by consolidating multiple tests into one. Achieves sensitivities comparable to targeted panels in critical genomic regions. Reduces the complexity of genomic data interpretation with specific features through the use of dedicated software.

Intended Audience/User

Laboratories seeking an expanded clinical exome solution for multiple indications (rare/hereditary diseases, carrier screening, hereditary cancer) with advanced analytical capabilities and comprehensive support.

Key Features

Expanded coverage of the clinical exome + mitochondrial genome + ~200 relevant non-coding variants.
Specific enhancements for hereditary cancer (94 genes) and carrier screening (155 genes).
Reliable detection of complex variants: 1–2 exon CNVs, Alu insertions, gene conversions (PMS2/PMS2CL, SMN1/SMN2, CYP21A2), Boland inversions (MSH2), repetitive tracts (CFTR).
Proven analytical performance: SNV/Indel sensitivity 99.8%; precision 99.0%; >99% of on-target regions at >25×/>50× coverage.
Unified and efficient workflow with advanced interpretation tools: ACMG scoring, virtual panel generation, duo and trio analysis, and reporting.
Direct integration capabilities with Alamut™ Visual Plus.
Access to the SOPHiA Genetics community to securely and anonymously share knowledge among specialists.
Expert support and cloud storage: secure, unlimited storage following industrial encryption standards and restricted access control to empower the interpretation of challenging variants.

Area:

Exomes, Hereditary and/or Rare Diseases, Molecular Genetics
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Devyser LynchFAP

Devyser LynchFAP is a targeted NGS solution for the analysis of germline variants associated with hereditary colorectal cancer syndromes. The assay enables the detection of SNVs, indels, and CNVs in genes related to Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), also incorporating a specific LR-PCR for the correct localization of variants in…
Devyser
Next Generation Sequencing (NGS)

Devyser HBOC NGS

Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron…
Devyser
Next Generation Sequencing (NGS)

Devyser BRCA NGS

Devyser BRCA NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1 and BRCA2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and copy number…
Devyser
Next Generation Sequencing (NGS)

Devyser BRCA PALB2 NGS

Devyser BRCA PALB2 NGS is a fast and robust NGS solution designed for the detection of genetic variants in the BRCA1, BRCA2, and PALB2 genes. It offers comprehensive and uniform coverage of all coding exons and exon/intron junctions of both genes. In addition, it includes the detection of single nucleotide variants (SNVs), insertions/deletions (Indels), and…
Devyser
Next Generation Sequencing (NGS)